Track topics on Twitter Track topics that are important to you
Equities analysts predict that Emergent Biosolutions, Inc. will announce sales of $175.41 million for the current quarter, Zacks reports. Two analysts have provided estimates for Emergent Biosolutions' earnings, with the highest sales estimate coming in at $179.71 million and the lowest estimate coming in at $171.10 million.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...